The 2027 sponsor and exhibitor list is not published yet (the organizer’s page still shows last year’s). We’ll add the exhibitors and their booths when it is, along with new sessions as the agenda fills in.

Upstream processing and cell culture at BPI West 2027

Mar 16–18, 2027 San Diego, CA ~800 attendees Website

14 organizations at BPI West 2027 present work in upstream & cell culture: 11 drug developers, 2 academic, government and non-profit bodies and 1 supplier or service provider. Between them they bring 57 presentations to the program. Most represented: Sanofi (8 on the program), AstraZeneca (7 on the program), Regeneron (7 on the program). As of Oct 15, 2026.

All 41 organizations at BPI West 2027 →

Showing 1–8 of 14 organizations

Organization	BPI West 2027 Attendance
Sanofi Paris, France
sanofi.com Large pharma Global pharmaceutical company developing and manufacturing biologics, vaccines and genomic medicines.	Talk Tue Mar 16 10:00am–10:30am Workshop 2 talk: title to be announced Workshop 2: Process Intensification in Practice: From Intensified to End-to-End Bioprocessing Talk Tue Mar 16 11:30am–12:00pm Orchestrating Continuous Purification Processes – Pilot Plant Case Studies Workshop 2: Process Intensification in Practice: From Intensified to End-to-End Bioprocessing Talk Wed Mar 17 11:15am–11:45am Mastering Complex Antibodies: Intelligent Design for High Titers and Superior Product Quality Cell Line Development & Engineering Talk Wed Mar 17 4:15pm–4:45pm Cell Culture Digital Twins for Improving Process Scale-Up How digital twins, computer models that mirror a cell culture process, help move it from lab to factory scale with consistent results. Talk Thu Mar 18 9:00am–9:30am Accelerating mRNA Vaccine Development with a Cell-Free DNA Template Platform Next-Gen Modality, Cell Therapy, and Gene Therapy Development & Production Talk Thu Mar 18 9:00am–9:30am Keynote Address: Are We Here Yet? A Digital Maturity Model for Enabling Process Monitoring and Artificial Intelligence in Biologics Manufacturing Accelerating Speed from Early Stage Development Through Commercial Manufacturing Talk Thu Mar 18 2:30pm–3:00pm Intelligent AAV Cell Line Development: AI-Powered Automation and Rapid Screening Cell Line Development & Engineering Also Presenting at the meeting, beyond the sessions above
AstraZeneca Cambridge, United Kingdom
astrazeneca.com Large pharma Global pharmaceutical company developing and manufacturing biologics, including antibodies and antibody-drug conjugates.	Talk Tue Mar 16 9:00am–9:30am Live Digital Twins and Agentic AI Enable Titer Prediction and Early Error Detection: Towards Self-Driving Biomanufacturing How live computer models predict product levels in bioreactors with steady medium flow and warn 8 to 24 hours before filters clog. Talk Tue Mar 16 9:00am–9:30am Workshop 2 talk: title to be announced Workshop 2: Process Intensification in Practice: From Intensified to End-to-End Bioprocessing Talk Wed Mar 17 2:00pm–2:30pm Accelerating Cell Line Development: Saving Time and Increasing Capacity Ways to speed up cell line development, the hunt for cells that make a drug well, and fit more projects through it. Talk Wed Mar 17 2:30pm–3:00pm Engineering Automated Sampling, Purification, and Analytical Methods to Facilitate Online Product Quality Monitoring to Support Bioprocess Development How an automated, sterile sampler drawing from 8 bioreactors lets chromatography track protein drug quality, such as clumping, almost in real time. Talk Wed Mar 17 4:45pm–5:15pm Mechanistic Modeling for Decision-Based Bioreactor Scale-Up How physics-based models of oxygen use and carbon dioxide buildup guided air bubbling and antifoam choices when scaling cell culture to manufacturing. Talk Thu Mar 18 2:00pm–2:30pm Beyond Ex Vivo CAR-T: Designing Lentiviral Vector Manufacturing for In Vivo Cell Therapy Why lentiviral vectors dosed straight into patients for cell therapy inside the body need new manufacturing standards beyond those built for lab-made CAR-T. Talk Thu Mar 18 2:00pm–2:30pm Cell Culture & Upstream Processing: title to be announced
Regeneron Tarrytown, New York
regeneron.com Large pharma Biopharmaceutical company with marketed antibody medicines and in-house biologics, gene therapy and cell therapy process development and manufacturing.	Talk Wed Mar 17 11:45am–12:15pm A High-Throughput Approach to Virus Retentive Filtration Process Development and Characterization How testing virus-removal filters under many conditions at once, varying pH, additives and protein levels, speeds development of this purification step. Talk Thu Mar 18 11:15am–11:45am Shared Session: AMBR Based Harvest PAR Models Cell Line Development & Engineering Talk Thu Mar 18 11:15am–11:45am Shared Session: AMBR Based Harvest PAR Models Cell Culture & Upstream Processing Talk Thu Mar 18 11:45am–12:15pm High Throughput Purification Automation Using Resin Slurry for Supplier Change Notifications Downstream Processing Talk Thu Mar 18 2:00pm–2:30pm Root-Cause Investigation of Protein A Ligand Leaching on Aged MabSelect SuRe Resin Downstream Processing Talk Thu Mar 18 2:30pm–3:00pm Accelerating Speed from Early Stage Development Through Commercial Manufacturing: title to be announced
Alexion Boston, Massachusetts
alexion.com Large pharma AstraZeneca's rare disease business, developing and manufacturing biologics for rare conditions.	Talk Wed Mar 17 10:00am–10:30am Optimizing Fed-Batch CHO Cell Culture Through Media and Feed Strategy to Improve Productivity and Product Quality Cell Culture & Upstream Processing Talk Wed Mar 17 11:15am–11:45am Intensified Fed-Batch Case Studies Cell Culture & Upstream Processing Talk Wed Mar 17 2:00pm–2:30pm Integrating Automation and Real-Time PAT for Enhanced Cell Culture Process Control Cell Culture & Upstream Processing Talk Wed Mar 17 2:00pm–2:30pm Understanding Drivers of Harvest Performance: From Process Specific Treatments to Cross Process Analysis Downstream Processing Talk Wed Mar 17 2:30pm–3:00pm Rapid Screening to Compare Process Conditions and Identify Low-Risk Conditions for PS80 Degradation in Downstream Process Development How a fast fatty acid test screens purification conditions early for ones that spare polysorbate 80, a detergent added to protein drugs. Also Presenting at the meeting, beyond the sessions above
Amgen Thousand Oaks, California
amgen.com Large pharma Global biopharmaceutical company developing and manufacturing biologic medicines.	Talk Tue Mar 16 9:00am–9:30am Workshop 1 talk: title to be announced Workshop 1: Tech Transfer Done Better: How to Minimize the Knowledge Gap Keynote Tue Mar 16 2:35pm–3:20pm Speed Without Shortcuts: How AI is Transforming CMC and Validation at Amgen BPI WEST Main Conference Opening Plenary CMC, Digital & Manufacturing Strategy Talk Wed Mar 17 9:30am–10:00am Cell Culture & Upstream Processing: title to be announced Talk Wed Mar 17 11:45am–12:15pm Cell Line Development & Engineering: title to be announced Talk Thu Mar 18 9:00am–9:30am End-to-End Automation of Cell Line Development: From Workflow Integration to Streamlined Execution Cell Line Development & Engineering Also Presenting at the meeting, beyond the sessions above
Bayer Leverkusen, Germany
bayer.com Large pharma Global pharmaceutical company with cell and gene therapy programs alongside its marketed medicines.	Talk Wed Mar 17 9:30am–10:00am Accelerating Speed from Early Stage Development Through Commercial Manufacturing: title to be announced Talk Wed Mar 17 10:00am–10:30am Product Development of a Phase III (and Beyond) Parkinson’s Allogeneic Cell Therapy using Process and Analytic Platforms How automated 2D and 3D culture platforms aim to make dopamine neurons for Parkinson's as an off-the-shelf therapy, cheaper and at scale. Talk Thu Mar 18 9:00am–9:30am Implementing a Lower-Cost Resin in a Licensed Process: A CMC Case Study Cell Culture & Upstream Processing Talk Thu Mar 18 9:00am–9:30am Implementing a Lower-Cost Resin in a Licensed Process: A CMC Case Study How an approved drug's purification switched to a cheaper chromatography resin, with small-scale tests showing the product unchanged through commercial validation. Talk Thu Mar 18 4:15pm–4:45pm Cell Culture & Upstream Processing: title to be announced
Novartis Basel, Switzerland
novartis.com Large pharma Global pharmaceutical company developing and manufacturing biologics and cell and gene therapies; also offers contract manufacturing capacity.	Talk Wed Mar 17 9:00am–9:30am Cell Line Development & Engineering: title to be announced Talk Wed Mar 17 11:45am–12:15pm Unlocking Productivity in an Upstream Continuous Process by Combining Media Concentrates and Multi-Phase Feeding Cell Culture & Upstream Processing Talk Thu Mar 18 2:00pm–2:30pm Accelerating Speed from Early Stage Development Through Commercial Manufacturing: title to be announced Talk Thu Mar 18 4:45pm–5:15pm Cell Line Development & Engineering: title to be announced
Astellas Tokyo, Japan
astellas.com Large pharma Pharmaceutical company with marketed medicines in oncology, urology and other areas, plus cell and gene therapy programs.	Talk Thu Mar 18 11:45am–12:15pm Shared Session: AAV upstream Development Through an Automated, High-Throughput Ambr250 Scale- Down Platform Cell Line Development & Engineering Talk Thu Mar 18 11:45am–12:15pm Shared Session: AAV upstream Development Through an Automated, High-Throughput Ambr250 Scale- Down Platform How a 2-liter process for making adeno-associated virus was scaled down, with automated transfection, to run more experiments using less material and labor. Talk Thu Mar 18 2:00pm–2:30pm Accelerating RPE Electroporation Optimization Through Design of Experiments How statistically planned experiments tuned electroporation, using electric pulses to deliver genes into cells, 5 times faster with 78% lower material costs.